• 2007

Company Description

TaiMed Biologics offers Ibalizumab, a monoclonal antibody and a member of HIV viral-entry inhibitor therapy.

TaiMed Biologics Inc. operates as a biotechnology company. The company develops Ibalizumab, a monoclonal Antibody (mAb) and a member of HIV viral-entry inhibitor therapy. TaiMed Biologics Inc. was founded in 2007 and is based in Taipei, Taiwan.

  • Manufacturer:

    Data and Analytics
  • Formed:

    2007
  • Founders:

    David Ho
  • Company Website:

  • Company E-mail:

  • Company Address:

    Room E1803 18th Floor, No 3 Yuan-Qu Street Nangang District
    Taipei
    Taiwan
  • CEO:

    • David Ho
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits